Epigenic Therapeutics is at the forefront of epigenetic medicine, focusing on the development of next-generation gene modulation therapies. Their proprietary technology, EPIREG®, employs advanced artificial intelligence algorithms to optimize CRISPR-Cas components, allowing for precise regulation of gene expression without altering the DNA sequence. This innovative approach mitigates risks associated with traditional gene editing methods, such as off-target effects and chromosomal abnormalities. The company has also developed a novel lipid nanoparticle (LNP) delivery system that enhances the safe and efficient delivery of epigenetic modulation tools to target cells, making it applicable across various therapeutic areas, including metabolic, cardiovascular, and oncological diseases.

In addition to their epigenetic modulation platform, Epigenic Therapeutics has established a comprehensive technology framework that includes immune and stem cell modulation. This platform enables precise DNA methylation and histone modification, enhancing the anti-tumor efficacy of therapies like CAR-T cell treatments while minimizing traditional gene editing risks. The integration of AI in their drug discovery process further accelerates the identification of new components for epigenetic modification, optimizing delivery specificity and improving overall therapeutic outcomes. Through these innovative technologies, Epigenic Therapeutics aims to address a wide range of challenging diseases, positioning itself as a leader in the biotechnology sector.

China

Epigenic Therapeutics is a frontier biotechnology company dedicated to developing next generation gene editing therapy utilizing regulation of epigenetic genome for a variety of diseases. Founded in 2021 by leading scientists focused on discovering gene editing technologies and developing gene editing therapies, the company has multiple product candidates in the pipeline, including treatment for metabolic, cardiovascular, viral hepatitis, ocular and rare diseases.

Epigenic Therapeutics

Company Details